Tea’s value as a cancer therapy is steeped in uncertainty

Michael Eisenstein

DOI: https://doi.org/10.1038/d41586-019-00397-2

IF: 64.8

2019-02-01

Nature

Abstract:<p>A reviving cup of tea is one of life’s pleasures — a tonic for the problems of daily life. But some people think that this refreshing beverage could have much greater restorative properties: there is evidence that tea, or some of its chemical components, can guard against cancer. The prospect is tantalizing, but after decades of population-based health studies, and even clinical trials in cancer patients, the scientific community is still far from a clear-cut answer.</p><p>Early hints of the potential of tea — green tea in particular — as a means of cancer prevention come from observations of geographical differences in cancer incidence, and efforts to identify lifestyle factors associated with these differences. “Population studies clearly show that the rates of clinically evident prostate cancer are much lower in Asian countries — especially in Japan and China, where 35% of the world’s tea is consumed,” says Nagi Kumar, a cancer-prevention researcher at the Moffitt Cancer Center in Tampa, Florida. “Those were the initial studies that got us started.”</p><p> <aside class="recommended pull pull--left sans-serif" data-label="Related"> <a href="https://nature.com/collections/rcpzjlzyzf" data-track="click" data-track-label="recommended article"><img class="recommended__image" src="//media.nature.com/w400/magazine-assets/d41586-019-00397-2/d41586-019-00397-2_16433360.jpg"><h1 class="recommended__title serif">Part of Nature Outlook: Tea</h1></a> </aside></p><p>Early epidemiological investigations from the 1980s and 1990s proved messy to interpret and offered conflicting results, but experiments exploring the pharmacological effects of tea’s constituent molecules on cancer cells were encouraging. “These compounds work beautifully in many experimental models and many cell culture systems,” says Hasan Mukhtar, a cancer researcher at the University of Wisconsin–Madison.</p><p>However, the enthusiasm of many working in this area of chemoprevention has been worn down by clinical trials that have proved inconclusive or shown only modest benefit. “When people ask me if tea prevents cancer, I say ‘Yes, no and perhaps,’” says Chung Yang at Rutgers University in Piscataway, New Jersey, who has studied the pharmacology of tea’s constituents for more than 30 years. “The animal studies are very strong, but there are no clear conclusions in humans.” </p><h2>Reading the leaves</h2><p>Green tea’s medicinal properties are primarily linked to a family of compounds known as catechins. The most important of these is epigallocatechin gallate (EGCG), which typically comprises 60–65% of the catechin content in a cup of green tea, and can be present at concentrations up to ten times higher than that of caffeine. EGCG has potent pharmacological effects both on cultured cancer cells and in mouse tumour models (see ‘Steeped with potential’). “This has turned out to be the most active compound in animal studies,” says Yang. However, in many cases the effective dose in animals might be impractical for use in humans; in some studies, the animals were given nothing but green tea or catechin-containing solutions to drink for the duration of the experiment.</p><figure class="figure"> <div class="embed intensity--highest"> <img class="figure__image" alt="" data-src="//media.nature.com/w800/magazine-assets/d41586-019-00397-2/d41586-019-00397-2_16433282.jpg"> <noscript> <img class="" alt="" src="//media.nature.com/w800/magazine-assets/d41586-019-00397-2/d41586-019-00397-2_16433282.jpg"> </noscript> <figcaption> <p class="figure__caption sans-serif"><span></span></p> </figcaption>

multidisciplinary sciences